Form 4: CVS Health Executive Reports Stock Withholding Transaction
Statement of Changes in Beneficial Ownership
CVS Health EVP and Chief Medical Officer Amy Compton-Phillips reported the surrender of 7,618 shares to cover tax obligations.
Summary
- Amy Compton-Phillips, EVP and Chief Medical Officer of CVS Health, executed a transaction involving the disposal of 7,618 shares of common stock.
- The transaction occurred on May 31, 2026, at a price of $90.98 per share.
- The disposal was a mandatory surrender of shares to satisfy tax withholding requirements related to the vesting of restricted stock units.
- Following this transaction, the reporting person maintains a direct beneficial ownership of 9,557 shares of CVS common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a mandatory tax settlement rather than a strategic market move.
Positives
- The transaction is a routine administrative action related to tax obligations rather than a discretionary sale of equity.
- The reporting person retains a significant stake of 9,557 shares, indicating continued alignment with shareholder interests.
Negatives
- The reduction in total shares held by the executive may be viewed as a minor decrease in direct equity exposure.
Risks
- None identified; this is a standard tax-related transaction.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that routine tax-related share surrenders by C-suite executives are standard corporate governance practices and do not typically signal a change in management sentiment regarding company performance.
Comparison to Industry Standards
- The transaction aligns with standard executive compensation practices observed in large-cap healthcare companies like Walgreens Boots Alliance and UnitedHealth Group, where equity vesting triggers automatic tax withholding.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a routine tax-related adjustment.
Key Dates
| Date | Description |
|---|---|
| 05/31/2026 | Date of the reported stock transaction. |
| 06/01/2026 | Date the Form 4 was signed and filed. |
Keywords
CVS Health, Insider Trading, Form 4, Executive Compensation, Tax Withholding, CVS
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.